Atlas Trials

Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells

Clinical trial NCT05628545 · WITHDRAWN

Trial details

NCT number
NCT05628545
Sponsor
Guangdong GD Kongming Biotech LLC
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Hepatocellular Carcinoma
Start date
2021-11-01
Primary completion
2023-02-28
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.